FERRARESI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2.784
EU - Europa 641
AS - Asia 461
OC - Oceania 4
Totale 3.890
Nazione #
US - Stati Uniti d'America 2.781
CN - Cina 277
UA - Ucraina 199
DE - Germania 117
TR - Turchia 112
IT - Italia 111
GB - Regno Unito 77
SG - Singapore 56
FI - Finlandia 43
SE - Svezia 33
BE - Belgio 18
PL - Polonia 10
FR - Francia 9
CZ - Repubblica Ceca 6
RO - Romania 6
IN - India 5
IE - Irlanda 4
CA - Canada 3
ID - Indonesia 3
IR - Iran 3
RU - Federazione Russa 3
AU - Australia 2
DK - Danimarca 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
VN - Vietnam 2
AL - Albania 1
JP - Giappone 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.890
Città #
Woodbridge 353
Fairfield 313
Chandler 249
Ann Arbor 224
Jacksonville 223
Houston 216
Ashburn 148
Seattle 143
Wilmington 124
Cambridge 108
Izmir 72
Boardman 71
Nanjing 67
New York 64
Ferrara 60
Beijing 51
Princeton 48
Singapore 32
Shanghai 29
Dearborn 23
Shenyang 23
Milan 22
San Diego 22
Jiaxing 19
Brussels 18
Nanchang 16
Bremen 15
Jinan 14
Hebei 13
Tianjin 13
Auburn Hills 11
Falls Church 11
Düsseldorf 10
Los Angeles 10
Warsaw 10
Redwood City 9
Mountain View 7
San Mateo 7
Washington 7
Brno 6
Norwalk 6
Changsha 5
Florence 5
Monmouth Junction 5
Ningbo 5
Chicago 4
Munich 4
Taizhou 4
Zhengzhou 4
Ardabil 3
Augusta 3
Frankfurt am Main 3
Jakarta 3
Kunming 3
Leawood 3
Orange 3
Philadelphia 3
Auckland 2
Copenhagen 2
Des Moines 2
Dong Ket 2
Dublin 2
Haikou 2
Hefei 2
Hong Kong 2
Padova 2
Swansea 2
Acton 1
Bologna 1
Bratislava 1
Bray 1
Celbridge 1
Changchun 1
Chengdu 1
Ferrara di Monte Baldo 1
Forest City 1
Hangzhou 1
Hanover 1
Helsinki 1
Hounslow 1
Hyderabad 1
Jinhua 1
Lappeenranta 1
London 1
Marienheide 1
Motta Di Livenza 1
New Delhi 1
Newmarket 1
Ottawa 1
Quzhou 1
Rockville 1
Saint Petersburg 1
Tappahannock 1
Tirana 1
Tokyo 1
Verona 1
Voghera 1
Winnipeg 1
Yinchuan 1
Totale 2.999
Nome #
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 142
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 135
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 123
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 115
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. 111
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 111
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 110
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 109
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 108
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 106
Factor IX propeptide mutation and life threatening bleeding 104
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 104
null 103
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 103
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 101
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 95
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency 95
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 93
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 90
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 89
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 86
null 82
null 78
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 77
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 76
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 74
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 74
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 73
null 73
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 70
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 69
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 67
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report 67
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 66
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 65
Factor VIIa levels, gene polymorphism and plasma lipids in subjects with or without angiographically proven coronary artery disease 63
Modulation Of Factor VII Expression By Repeat And Sequence Variations In The Intron 7 Of FVII Gene: Population And In Vitro Studies 63
null 61
null 61
Strong contribution of FVII genotypes to activated FVII levels and differences in genotype frequencies in northern and southern European countries 56
Non-conventional therapeutic strategies for inherited disorders of hemostasis 55
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 52
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 51
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 45
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 40
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 28
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 24
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 21
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 19
Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype 15
The heterozygous 20210 G/A genotype prevalence in patients affected by central and branch retinal vein occlusion: a pilot study. 14
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII 13
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction 11
Totale 3.936
Categoria #
all - tutte 15.325
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.325


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020905 144 32 32 128 62 107 87 94 71 101 36 11
2020/2021580 59 44 25 66 34 61 28 72 14 71 82 24
2021/2022476 21 55 34 23 21 9 24 15 9 32 62 171
2022/2023525 56 53 16 79 75 79 18 41 63 2 23 20
2023/2024354 31 26 7 6 30 78 10 26 9 19 11 101
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 3.936